Micropharma launches new microbiome supplements direct to healthcare practitioners Microbiome Plus+ Bone, Heart and GI are the first disease specific microbiome-based supplements to market

MONTREAL, Dec. 10, 2013 /PRNewswire-iReach/ -- Micropharma Limited, a pioneer in the development of microbiome based technologies announced today the launch of an innovative new line of dietary supplements called Microbiome Plus+. Microbiome Plus+ products are the first line of dietary supplements based on the exciting new science of the microbiome. Microbiome Plus+ products combine microbiome based support with other proven natural ingredients to provide more complete dietary support for bone, heart and gastrointestinal health. Microbiome Plus+ products are natural, effective, safe solutions that are allergen and gluten free.  The ingredients in Microbiome Plus+ products are of the highest quality have extensive clinical proof and are from renewable and sustainable sources.

(Photo: http://photos.prnewswire.com/prnh/20131210/MN30125)

There are three Microbiome Plus+ products, Microbiome Plus+ Bone, Microbiome Plus+ Heart and Microbiome Plus+ Gastrointestinal, each specifically formulated to support bone, heart and gastrointestinal health.

Microbiome Plus+ Bone is a more complete bone health dietary supplement that provides full daily dietary recommended intake of calcium, and vitamin D3 and the probiotic L. reuteri NCIMB 30242, which helps maintain healthy levels of vitamin D in the body.*

Microbiome Plus+ Heart is a more complete heart health dietary supplement that provides the full American Heart Association daily dietary recommendation of omega-3 plus the probiotic L. reuteri NCIMB 30242, which supports normal cholesterol levels and inflammatory response.*

Microbiome Plus+ Gastrointestinal is a more complete gastrointestinal health dietary supplement that provides natural prebiotic fiber (scFOS) and the probiotic L. reuteri NCIMB 30242 which work together to maintain the balance of healthy bacteria in your gut and support normal digestive function. *

In an interview with Nutra Ingredients-USA, Ryan Jones was quoted as saying "Micropharma is one of six commercial companies in the world that is actually creating microbiome commercial products; taking advantage of a half a billion dollars-worth of microbiome research."

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Micropharma is a Quebec based Canadian company.

About Microbiome Plus

Microbiome Plus+ Bone, Heart and Gastrointestinal are more complete dietary supplements based on the science of the microbiome, plus essential nutrients that are natural, effective and safe solutions. For more info go to www.microbiomeplus.com

About Micropharma Limited

Micropharma is a Canadian biotechnology company focused on human health through the microbiome. The company applies a unique approach, ProSelect, to the discovery and commercialization of novel products based on the human microbiome for the diagnosis and treatment of metabolic diseases.  Micropharma works on disease specific products with clear microbiome related mechanisms, and links to biomarkers that are associated with improving human health.  Micropharma is developing diagnostics and oral biologic therapies in the area of metabolic disease including hypercholesterolemia, metabolic syndrome, obesity, and diabetes.  For more info go to www.micropharma.net

To view this video on YouTube, please visit: http://www.youtube.com/watch?v=Z-SxrZg9sN8

Media Contact: Christopher Wahl MD, MBA, Micropharma Limited, 514-524-2828, cwahl@micropharma.net

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Micropharma Limited




Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.